|-||In case of accidental exposure e.g. skin pricks, spillage into eye or mouth, bites or scratches, contamination of abrasions, in non-immunised subjects (including persons whose vaccination is incomplete or status unknown).|
|-||In the newborn of a hepatitis B virus carrier-mother.|
|-||In persons who have been in sexual or intimate physical contact with HBsAg-positive persons.|
|-||In haemodialysed patients, until vaccination has become effective.|
|-||In subjects who did not show an immune response (no measurable hepatitis B antibodies or < 10 IU/L of hepatitis B antibodies) after vaccination and for whom a continuous prevention is necessary due to the continuous risk of being infected with hepatitis B.|
|INDICATIONS||SINGLE DOSE||SPECIAL INSTRUCTIONS|
|Age:10 years to adult : 500 IU
Age 5 - 9 years (inclusive): 300 IU
Age 0 - 4 years (inclusive) : 200 IU
|Treat preferably within 48 hours, and not more than 7 days after exposure.|
Repeat after 28 days unless recipient has been shown to be immune or has received hepatitis B vaccine.
|Haemodialysis||8 - 12 IU/kg (Maximum 500 IU)||Hebagam IM administration may need to be repeated every 2 months until seroconversion following vaccination.|
|Newborn babies born to HBsAg positive mothers (especially those who are hepatitis B envelope antigen (HBeAg) positive)
||200 IU||Treat preferably at birth, or within 48 hours after birth.|
First dose of hepatitis B vaccine must be administered at the same time.
Hebagam IM administration may need to be repeated until seroconversion following vaccination.
|In subjects who do not show an immune response after vaccination and for whom continuous prevention is necessary||Adults: 500 IU
Children: 8 IU/kg
|Every 2 months|
(a minimum protective antibody titre is considered to be 10 IU/L)
|PRIVATE BAG X9043||10 EDEN ROAD|
|Telephone:||086 016 2472|
|Telefax:||031 708 5614|